FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104355310> ?p ?o ?g. }

• W2104355310 abstract "TP53 defects, i.e., 17p13 deletion and/or nucleotide mutations, associate with short survival and chemorefractoriness in chronic lymphocytic leukemia (CLL). In this context, since direct sequencing of the TP53 gene does not evaluate TP53 functionality, a functional assessment of TP53 pathway may be of interest to identify high risk CLL. By taking advantage of a training cohort of 100 CLL and a validation cohort of 40 CLL with different patterns of TP53 mutation/deletion by FISH and sequencing, we propose an in-vitro assay in which the modulation of TP53 protein and CDKN1A mRNA were investigated upon 24-hour exposure of CLL cells to Nutlin-3.The functional assay was set-up on cell lines recapitulating all TP53 genotypes (EHEB, TP53(wt/wt); RAJI, TP53(mut/wt); MEC-1 and MAVER1, TP53(mut/del); HL-60, TP53(del/del)) and evaluated in two multi-institutional cohorts, purposely enriched in CLL bearing TP53 disruption: a training cohort of 100 cases and a validation cohort of 40 cases, both characterized by FISH and TP53 direct sequencing. Cells were exposed to 10 µM Nutlin-3 for 24 hours; TP53 accumulation was evaluated by Western blotting; TP53 transcriptional activity was determined by quantitative realtime PCR (qRT-PCR) of the TP53 target gene CDKN1A.According to TP53 protein modulation, in the training cohort we identified: (i) 63 cases (51 TP53wt/wt, 12 TP53del/wt) with absence of basal TP53 and induction after treatment (normal pattern); (ii) 18 cases (3 TP53(mut/wt), 15 TP53(mut/del)) with high basal TP53 without increase after treatment (mutant pattern); (iii) 19 cases (5 TP53(mut/wt); 3 TP53(mut/del); 11 TP53(wt/wt)) with basal TP53 that increases upon treatment (intermediate pattern). Evaluation of CDKN1A mRNA levels upon Nutlin-3 exposure showed that the 26 TP53 mutated (TP53(mut/del) or TP53(mut/wt)) cases had lower induction levels than the majority (57/63) of cases with normal pattern, and 10/12 cases with intermediate pattern without evidence of TP53 derangement by FISH and sequencing. These results were confirmed in the independent validation cohort of 40 cases (13 TP53(wt/wt), 3 TP53(del/wt), 12 TP53(mut/del), 12 TP53(mut/wt)).The proposed functional assay may integrate the conventional analyses for the identification of TP53 dysregulated CLL." @default.
• W2104355310 created "2016-06-24" @default.
• W2104355310 creator A5008348763 @default.
• W2104355310 creator A5009431453 @default.
• W2104355310 creator A5009661062 @default.
• W2104355310 creator A5012114658 @default.
• W2104355310 creator A5015790909 @default.
• W2104355310 creator A5018250263 @default.
• W2104355310 creator A5019453308 @default.
• W2104355310 creator A5028533961 @default.
• W2104355310 creator A5038163660 @default.
• W2104355310 creator A5039006383 @default.
• W2104355310 creator A5039878860 @default.
• W2104355310 creator A5041745367 @default.
• W2104355310 creator A5043662372 @default.
• W2104355310 creator A5047961182 @default.
• W2104355310 creator A5062765629 @default.
• W2104355310 creator A5068835269 @default.
• W2104355310 creator A5071089132 @default.
• W2104355310 creator A5073179633 @default.
• W2104355310 creator A5075079041 @default.
• W2104355310 creator A5091091710 @default.
• W2104355310 date "2013-11-05" @default.
• W2104355310 modified "2023-10-14" @default.
• W2104355310 title "Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application" @default.
• W2104355310 cites W146673805 @default.
• W2104355310 cites W1650797637 @default.
• W2104355310 cites W1968123077 @default.
• W2104355310 cites W1979319210 @default.
• W2104355310 cites W1980260104 @default.
• W2104355310 cites W1986076152 @default.
• W2104355310 cites W1993986769 @default.
• W2104355310 cites W1998612932 @default.
• W2104355310 cites W2001480298 @default.
• W2104355310 cites W2009288597 @default.
• W2104355310 cites W2012053348 @default.
• W2104355310 cites W2034156576 @default.
• W2104355310 cites W2039108801 @default.
• W2104355310 cites W2049882979 @default.
• W2104355310 cites W2055349083 @default.
• W2104355310 cites W2064965338 @default.
• W2104355310 cites W2069401990 @default.
• W2104355310 cites W2085491264 @default.
• W2104355310 cites W2086956752 @default.
• W2104355310 cites W2096036897 @default.
• W2104355310 cites W2096139220 @default.
• W2104355310 cites W2113895281 @default.
• W2104355310 cites W2115577067 @default.
• W2104355310 cites W2123124709 @default.
• W2104355310 cites W2124920464 @default.
• W2104355310 cites W2134942110 @default.
• W2104355310 cites W2142099365 @default.
• W2104355310 cites W2142184993 @default.
• W2104355310 cites W2146449972 @default.
• W2104355310 cites W2159354924 @default.
• W2104355310 cites W2159880472 @default.
• W2104355310 cites W2161274278 @default.
• W2104355310 cites W2163923077 @default.
• W2104355310 cites W2168492136 @default.
• W2104355310 cites W2289050278 @default.
• W2104355310 cites W2318933236 @default.
• W2104355310 cites W2323897083 @default.
• W2104355310 cites W4376595664 @default.
• W2104355310 doi "https://doi.org/10.1186/1756-8722-6-83" @default.
• W2104355310 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4222122" @default.
• W2104355310 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24283248" @default.
• W2104355310 hasPublicationYear "2013" @default.
• W2104355310 type Work @default.
• W2104355310 sameAs 2104355310 @default.
• W2104355310 citedByCount "16" @default.
• W2104355310 countsByYear W21043553102014 @default.
• W2104355310 countsByYear W21043553102016 @default.
• W2104355310 countsByYear W21043553102017 @default.
• W2104355310 countsByYear W21043553102018 @default.
• W2104355310 countsByYear W21043553102019 @default.
• W2104355310 countsByYear W21043553102020 @default.
• W2104355310 countsByYear W21043553102021 @default.
• W2104355310 countsByYear W21043553102023 @default.
• W2104355310 crossrefType "journal-article" @default.
• W2104355310 hasAuthorship W2104355310A5008348763 @default.
• W2104355310 hasAuthorship W2104355310A5009431453 @default.
• W2104355310 hasAuthorship W2104355310A5009661062 @default.
• W2104355310 hasAuthorship W2104355310A5012114658 @default.
• W2104355310 hasAuthorship W2104355310A5015790909 @default.
• W2104355310 hasAuthorship W2104355310A5018250263 @default.
• W2104355310 hasAuthorship W2104355310A5019453308 @default.
• W2104355310 hasAuthorship W2104355310A5028533961 @default.
• W2104355310 hasAuthorship W2104355310A5038163660 @default.
• W2104355310 hasAuthorship W2104355310A5039006383 @default.
• W2104355310 hasAuthorship W2104355310A5039878860 @default.
• W2104355310 hasAuthorship W2104355310A5041745367 @default.
• W2104355310 hasAuthorship W2104355310A5043662372 @default.
• W2104355310 hasAuthorship W2104355310A5047961182 @default.
• W2104355310 hasAuthorship W2104355310A5062765629 @default.
• W2104355310 hasAuthorship W2104355310A5068835269 @default.
• W2104355310 hasAuthorship W2104355310A5071089132 @default.
• W2104355310 hasAuthorship W2104355310A5073179633 @default.
• W2104355310 hasAuthorship W2104355310A5075079041 @default.
• W2104355310 hasAuthorship W2104355310A5091091710 @default.
• W2104355310 hasBestOaLocation W21043553101 @default.

• next